Top 35% EcoVadis Global Ranking Recognizes Scantox’s ESG Leadership as a Preclinical Partner
Scantox, a leading contract research organization (CRO) supporting nonclinical development in pharma and biotech, has been awarded a Bronze Medal by EcoVadis, placing Scantox in the top 35% of companies assessed worldwide. This recognition reflects our deliberate, long-term approach to environmental, social, and ethical responsibility—and reinforces our alignment with international ESG standards.
“This recognition affirms our belief that science and sustainability must go hand-in-hand. At Scantox, we’re proud to be a partner that delivers not only scientific excellence, but does so with transparency, accountability, and long-term impact in mind.”
— Jeanet Løgsted, CEO, Scantox Group
What Is EcoVadis—and Why Does It Matter?
EcoVadis is a widely adopted sustainability assessment system used across industries—including pharma and biotech—to evaluate how companies manage environmental, social, and ethical practices. It reviews organizations across four key themes:
- Environment
- Labor & Human Rights
- Ethics
- Sustainable Procurement
Many of our clients reference EcoVadis ratings as part of their supplier qualification, ESG reporting, and risk management processes. The assessment provides a standardized, third-party view of a company’s sustainability practices and supporting documentation.
In 2024, EcoVadis raised the bar—tightening both scoring and medal thresholds. Scantox’s Bronze Medal places us in the top 35% of companies assessed globally under these more rigorous criteria. It reflects the maturity of our ESG systems and our alignment with international expectations for responsible business conduct.
Key Highlights of Scantox’s 2025 Sustainability Performance
- Ranked in the 71st percentile globally, earning Bronze Medal status (Top 35%)
- Completed the transition to 100% renewable electricity across all sites
- Installed 1,628 solar panels at headquarters in Denmark
- Provides real-time CO₂ emissions data at study level to support client Scope 3 tracking
- Received limited assurance from auditors on group-wide environmental targets
- Awarded full AAALAC accreditation in 2025, affirming gold-standard animal welfare
- Expanded facilities designed to support biodiversity and outdoor enrichment
- Upholds labor and human rights principles, aligned with international standards
- Implements global governance policies and a digital SOP system to ensure compliance, ethics, and transparency across operations
- Maintains standardized training programs supporting ethical conduct, safety, and regulatory compliance
- Surpassed our 5% target in 2024, with 6% of staff in internships or certified training roles—demonstrating our commitment to talent development and workforce-readiness in the broader life sciences community
- Public ESG reporting through our Annual Report ESG Summary
A Sustainable CRO Partner
Sustainability is built into how Scantox operates—from how we source energy and manage facilities to how we train, report, and collaborate. Our approach balances scientific rigor with ethical responsibility, offering measurable impact to the clients we serve.
“We apply the same discipline to sustainability as we do to science—structured thinking, traceable data, and continuous refinement. In 2024, we introduced AI-driven ESG tracking to improve transparency and streamline compliance, enabling broader sustainability efforts.
As a member of the pharmaceutical supply chain, we’re advancing responsible, innovative practices that support our clients’ ESG goals and build long-term resilience—together.”
— Nicolai Oliver Anazom-Nielson, Head of Sustainability, Scantox Group
In parallel with our environmental progress, we’ve strengthened governance by formalizing global policies that exceed compliance requirements and embedding ESG responsibility across roles. Our approach to talent development—including internships, professional training, and board-level certifications—advances innovation while contributing to social responsibility and workforce readiness across the broader life sciences community.
What This Means for Our Clients
Advance Your Sustainability Goals: Scantox’s practices align with international ESG frameworks—supporting your own emissions targets, supplier assessments, and reporting obligations.
Transparent, Third-Party Validation: Our EcoVadis rating offers independent insight into our operations, strengthening confidence in procurement and partnership decisions.
Reliable, Low-Risk Supply Chain Partner: Our strong ESG profile helps mitigate reputational, compliance, and operational risk across your vendor ecosystem.
Prepared for Evolving Expectations: As ESG becomes central in RFPs, audits, and stakeholder disclosures, our documented approach helps clients stay ahead of shifting expectations.
Commitment to Workforce Development: We invest in next-generation talent and professional training—ensuring the scientific expertise supporting your programs is sustainable, future-ready, and aligned with evolving industry needs.
Shared Responsibility for Sustainable Science: We view ESG not as an obligation, but as a shared commitment—with practices that benefit our clients, our communities, and the broader scientific ecosystem.
Looking Ahead
This EcoVadis Bronze Medal is an acknowledgment of the systems we’ve built—and the direction we’re heading. Scantox will continue investing in ESG initiatives that matter to our clients: advancing our SBTi-aligned climate commitments, expanding emissions transparency, and delivering sustainability-conscious preclinical services that help accelerate therapeutic progress while strengthening the resilience and responsibility of the pharmaceutical supply chain.
Frequently Asked Questions
What is EcoVadis and why does it matter in the pharmaceutical supply chain?
EcoVadis is a commonly used platform for third-party evaluation of corporate sustainability practices. It assesses companies across four core areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.
In pharma and biotech supply chains, where sponsors’ expectations around sustainability and ESG performance are becoming more clearly defined, platforms like EcoVadis are used to assess the maturity of their CRO partners’ sustainability practices in a consistent and comparable way.
What does Scantox’s EcoVadis Bronze Medal signify?
Our Bronze Medal places Scantox Group in the top 35% of companies rated globally by EcoVadis. That recognition reflects more than compliance—it shows that we’ve built meaningful systems to manage and improve ESG performance across our business, aligned with global sustainability standards.
Why is this recognition relevant to Scantox customers?
Sustainability is now a strategic procurement priority—not just for large pharma, but increasingly for biotechs and emerging sponsors. Scantox’s EcoVadis rating provides third-party assurance that we’re a values-aligned partner—supporting our customers’ ESG reporting, risk management, and responsible sourcing goals, while advancing their research programs with the scientific rigor and responsiveness needed to accelerate progress toward the clinic—together.
Has Scantox committed to Science-Based Targets Initiative (SBTi)?
Yes. Scantox has formally committed to setting near-term emissions reduction and net-zero targets through the Science Based Targets initiative (SBTi). This reflects our alignment with global climate goals—and our belief that agile, mid-sized organizations like ours have a real opportunity to lead by acting decisively and transparently.
What specific actions is Scantox taking to reduce environmental impact?
Scantox has transitioned to 100% renewable electricity across our operations and installed 1,628 solar panels at our headquarters. We also provide real-time CO₂ emissions data at the study level—enabling our clients to quantify Scope 3 emissions with clarity and accountability.
How does Scantox approach animal welfare in the context of sustainability?
In 2025, our facilities in Denmark were awarded full AAALAC accreditation, reflecting the highest standards in ethical animal care. Our sites are designed with sustainability and welfare in mind—including outdoor enrichment areas, positive reinforcement programs, and biodiversity-conscious facility planning.
Where can I find more information about Scantox’s ESG strategy?
Visit our ESG resource page to learn more about our commitments, download our Annual Report Summary, and see how we’re building sustainability into every part of our scientific and operational model.
Discover Scientific Insights On Demand
Access our full library of scientific webinars—led by Scantox’s experts in discovery and nonclinical development. Explore strategic insights and practical approaches to support smarter decisions and accelerate your development program.
